HY21 result: InvoCare (ASX:IVC) share price jumps 8%

The InvoCare Limited (ASX: IVC) share price has gone up 8% after releasing its FY21 half-year result.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The InvoCare Limited (ASX: IVC) share price has gone up 8% after releasing its FY21 half-year result.

InvoCare’s FY21 half-year result

online pharmacy neurontin for sale no prescription

Invocare reported that its revenue increased by 13% to $260.9 million.

The company said that in Australia, operating revenue has grown in all markets with a 6.6% increase in operating revenue, driven by a 6.7% increase in funeral prices, while volumes were in line with the prior corresponding period.

In New Zealand, there was a 5.8% increase in operating revenue to $26.3 million. Singapore revenue, in local currency terms, increased by 3.4% to S$9.5 million.

The funeral operator said that total operating EBITDA (EBITDA explained) grew by 31% to $63.6 million. Management pointed out there was a return to positive operating leverage. Operating EBIT grew 46% to $39.4 million.

The operating profit / earnings per share (EPS) went up 57% to 14.4 cents.

Dividend

InvoCare’s board decided to pay an interim dividend of 9.5 cents per share, which was a dividend payout ratio of 66%. This was an increase of 72.7% compared to a year ago.

Outlook for InvoCare and the share price

InvoCare warned that the Delta variant spread in Australia is expected to lead to a softening of the funeral services market in the second half of 2021. So management couldn’t provide guidance.

But, management are confident about the long-term potential of the business, with future growth supported by population and ageing trends in its operating markets.

InvoCare said that it will continue to leverage its national footprint in pet cremations with national supply agreements with key veterinary groups.

The company is also doing a number of initiatives to strengthen its position as it aims to lead the industry when it comes to sustainability, innovation and community engagement.

Management said that this FY21 first half result was a sign of the strength of the business when conditions permitted.

InvoCare is an interesting business. As the saying goes, there are only two things certain in life – death and taxes. The company is expected to benefit from the ageing demographics.

But it’s not exactly cheap at 35 times the estimated earnings for the 2022 financial year, according to CommSec numbers.

If you’re looking to learn how to do your own ASX company valuations, take our free share valuation course

online pharmacy buy desyrel no insurance with best prices today in the USA
online pharmacy buy amaryl without prescription with best prices today in the USA

, which takes you through 6 common share valuation techniques, step by step. Or try our Beginner Shares Course if you’re just starting out. Both are free.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.